Thoracic radiation is associated with significant cardiopulmonary morbidities in long-term Hodgkin lymphoma (HL) survivors and may impact neurocognitive outcomes. Survivors (N=204, 52.5% female, mean[SD] age 36.6[8.01] years), treated with thoracic radiation, and age-, sex- and race/ethnicity-matched community controls (N=205, 51.7% female, age 36.7[9.17] years) completed standardized neurocognitive testing, echocardiography, pulmonary function tests, and vascular studies during the same visit. Treatments were abstracted from medical records. Cardiac (i.e., left ventricular ejection fraction [LVEF], global longitudinal strain [GLS]), vascular (i.e., large [LAE] and small artery elasticity [SAE]), pulmonary (i.e., diffusing capacity of the lungs for carbon monoxide [DLCO], forced expiratory volume [FEV1]), and chronic health conditions were evaluated for associations with age-adjusted neurocognitive performance using multivariable linear regression. Compared to controls, survivors had lower performance (P's<0.05) in visuomotor (0.11 v 0.41), visual processing speed (0.25 v 0.64), short-term recall (-0.24 v 0.12), and flexibility (-0.04 v 0.28). Survivors had lower pulmonary (FEV1 82.69% v 96.23%; DLCOcorr 83.31% v 98.03%), cardiac (LVEF 56% v 60%; GLS -18.30% v -20.37%), and vascular function (SAE 6.94 v 8.25 mL/mm Hg) than controls (all p's<0.001). FEV1 was associated with visuomotor (β[95% CI] 0.11[0.003-0.02], p=0.008) and visual processing speed (0.01[0.004-0.20], p=0.05), and flexibility (0.01[-0.001-0.03], p= 0.05). GLS was associated with short-term recall (0.06[0.005-0.11], p=0.03). SAE was associated with flexibility (0.09[0.02-0.16], p=0.007). Neurocognitive outcomes were also associated with moderate to severe neurologic chronic conditions (p's<0.05). Findings suggest a link between subclinical cardiopulmonary and vascular findings, neurologic morbidity, and neurocognitive impairments. Prevention of health morbidity may benefit neurocognitive outcomes.